The study was based on human clinical evidence that homozygous mutations of USH2A result in Usher syndrome type 2 [13], as well as recent evidence that heterozygous USH2A mutations may be a genetic risk factor for CAPD [24]. The gene discussed is USH2A; the disease is Usher syndrome type 2.